UK Mounjaro price update explained
Mounjaro Price Increase UK: Why Costs Changed and What It Means for Patients
Mounjaro® (tirzepatide) prices changed in the UK after Eli Lilly increased the UK list price from September 2025. This guide explains why prices rose, how the increase affected private treatment, and what patients should check before continuing treatment.
At Live Well Weight Loss, we aim to keep pricing transparent while maintaining a safe, clinically reviewed service for eligible patients.
Written by: Live Well Weight Loss Pharmacy Team
Clinically reviewed by: Moazma Ahmed, Pharmacist Independent Prescriber, GPhC 2069977
Last reviewed: June 2026
Next review due: September 2026
Quick Answer: Why Did Mounjaro Prices Increase in the UK?
Mounjaro prices increased in the UK after the manufacturer, Eli Lilly, raised the UK list price from 1 September 2025. This increased the medicine cost paid by pharmacies and private providers, especially for higher-dose Mounjaro pens.
Private treatment prices may also reflect the cost of regulated clinical checks, prescribing, identity and suitability assessment, cold-chain delivery, supplies, patient support and ongoing monitoring.
Important: Mounjaro is a prescription-only medicine. It should only be supplied after a proper clinical assessment by an appropriate prescriber. Very low prices, bulk-buy offers, or sellers offering treatment without prescription checks may be unsafe.
What Changed in September 2025?
In September 2025, the UK list price for Mounjaro changed. Reports at the time stated that pharmacy cost prices were increasing from previous lower levels to higher dose-related prices.
The increase meant private pharmacies and providers faced higher medicine purchase costs. This affected the final monthly price paid by many private patients.
Lilly does not set the final price charged by private pharmacies. Each provider sets its own patient price based on medicine cost, clinical service model, delivery, supplies, operating costs and the level of support included.
Why the Price Increase Affected Private Patients
Private providers usually purchase medicines through wholesale supply routes. When the list price or pharmacy purchase cost increases, the cost of supplying treatment privately can also increase.
This does not mean every provider will charge the same amount. Private treatment costs can differ because services are structured differently. Some providers include clinical review, supplies and delivery in the headline price, while others may separate some costs or offer a different level of follow-up.
For current provider-by-provider pricing, visit our dedicated Mounjaro price comparison UK page.
Live Well’s Response to the Mounjaro Price Increase
At Live Well Weight Loss, we aim to keep Mounjaro pricing clear while maintaining appropriate clinical standards. Our pricing reflects the medicine cost as well as the clinical and operational work needed to supply treatment safely.
Our service includes a clinical assessment, prescriber review, appropriate dispensing, cold-chain delivery and ongoing support where treatment is approved.
Note: Treatment is only supplied where clinically appropriate. Completing an order or consultation does not guarantee supply.
Patients should always check the latest product information and current price before ordering, as medicine costs and service pricing can change over time.
What Is Included in the Live Well Weight Loss Service?
When considering private Mounjaro treatment, it is important to understand what the service includes. A responsible treatment pathway should involve more than simply posting a medicine.
Clinical assessment
Eligibility, BMI, medical history, current medicines and suitability are reviewed before supply.
Prescriber review
Treatment is reviewed by an appropriate prescriber before medication is supplied.
Cold-chain delivery
Temperature-sensitive medicines require suitable packaging and delivery processes.
Ongoing support
Patients may need advice about side effects, missed doses, dose changes and treatment continuation.
What Patients Should Check After the Price Increase
Price is important, especially for patients paying privately each month. However, Mounjaro should not be treated like a normal online purchase. Safety, suitability and follow-up matter.
| What to check | Why it matters |
|---|---|
| Is the pharmacy GPhC-registered? | This helps confirm you are using a regulated UK pharmacy. |
| Is there a real clinical assessment? | Mounjaro is not suitable for everyone and requires screening before prescribing. |
| Are delivery and supplies included? | Some services may separate costs for delivery, needles, wipes or sharps disposal. |
| Is follow-up support available? | Patients may need help with side effects, dose changes, missed doses and maintenance. |
| Does the offer seem unsafe or unrealistic? | Avoid sellers offering prescription medicines without proper checks or pharmacy details. |
Does the Mounjaro Price Increase Affect NHS Patients?
NHS pricing and private pricing are different. Reports at the time of the UK list price change noted that separate arrangements applied to NHS supply and access.
NHS access to Mounjaro for weight management remains subject to NHS eligibility criteria, local pathways and availability. Private access is separate and still requires an appropriate clinical assessment and prescription.
Why Safe Supply Matters After a Price Rise
When medicine prices increase, some patients naturally look for cheaper options. That is understandable. However, very low prices or shortcuts can be risky with prescription-only medicines.
Safe supply means checking eligibility, reviewing side effects, managing dose changes carefully, ensuring correct storage and delivery, and making sure patients know when to seek medical advice.
Avoid unsafe Mounjaro sellers
- No prescription or consultation required
- Bulk-buy offers without clinical checks
- Social media, marketplace or WhatsApp sellers
- No UK pharmacy registration details
- No clear prescriber information
- Unrealistically low prices
Frequently Asked Questions
Need Current Mounjaro Pricing?
This article explains why prices changed. For current dose-by-dose provider pricing, use our dedicated Mounjaro price comparison guide.
View Mounjaro Price Comparison GuideRelated Guides
References
- Community Pharmacy England. Mounjaro reimbursement prices redetermined for September 2025.
- NHS Business Services Authority. Mounjaro price increase and Drug Tariff redetermination information.
- The Pharmaceutical Journal. UK pharmacy reporting on Mounjaro list price changes, August 2025.
- Electronic Medicines Compendium. Mounjaro KwikPen Summary of Product Characteristics.
- NICE TA1026. Tirzepatide for managing overweight and obesity.
